Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis by spinsupport | Oct 5, 2021
Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders by Jon McLaren | Apr 7, 2021
